The Future is not a place we are going, but a place we are creating.
First in mind...next in will…then in activity.
The FSHD Society's dedicated staff and committed volunteers bring extraordinary knowledge, expertise, organizational skills, and a great sense of urgency to carrying out our mission. It is the coordinated effort we build with volunteers, patients, family members, healthcare professionals, research leaders, industry, and governments that will lead us to treatments by 2025 and then on to a cure.
Senior Management

Mark Stone
Chief Executive Officer

Beth Johnston
Chief Community
Engagement Officer

Ken Kahtava
Chief Operating Officer

Carolyn Lloyd
Chief Development Officer


Michelle Mellion, MD
Medical Advisor

Agnes Mestrich
Chief Financial Officer

Lucienne Ronco, PhD
Chief Science Officer
Board of Directors
Leadership

James A. Chin Sr.
Board Chair

Howard L. Chabner
Vice Chair

George Pollock Jr.
Treasurer

William Sarraille
Secretary

Amy Bekier
Chair, Governance Committee

Jack Gerblick
Chair, Community Engagement Committe

Lee (Frank) Kolakowski
Chair, Therapeutic Accelerator & Research Committee

Stuart Lai
Chair, Patient Engagement Committee
General Members

Mel Hayes

Robert E. Humphreys, Jr.

Linda Laurello

William R. Lewis III

Michelle Mackay

Chris Mancill

Bruce Ryskamp

Jason Shi

Neil A. Solomon

William R. Lewis, Sr., MD
Emeritus
